PARK WEST ASSET MANAGEMENT LLC Theravance Biopharma, Inc. Transaction History

PARK WEST ASSET MANAGEMENT LLC portfolio value:

$19.46M
portfolio value

PARK WEST ASSET MANAGEMENT LLC quarter portfolio value change:

+11.92%
quarter

Theravance Biopharma, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -39.51% -1.25M shares -9.28M $10.14 1.91M
Q2 2022 share Increase +833.31% 2.83M shares 25.5M $9.06 3.17M
Q1 2022 share Increase 0.00% 340K shares 3.25M $9.56 340K